Anwar Ibrahim, Malaysia's Prime Minister, has announced a significant financial achievement for the government. By opting for generic drugs over expensive originator medicines, the government has saved approximately RM1 billion. This decision, made two years ago, marks a shift away from the outdated practice of relying heavily on costly drugs from the US and Europe. Anwar emphasized that Malaysia could have saved tens of billions of ringgit by purchasing generic drugs from countries like India, Turkey, Brazil, and China, which offer the same medication at a fraction of the cost. This move aligns with the government's commitment to making healthcare more accessible and affordable for its citizens.
Anwar, who also serves as the finance minister, highlighted the importance of expediting public health infrastructure projects. He criticized the lengthy timelines for hospital construction, stating that it should not take nearly a decade. The new Seberang Jaya hospital building, which began in 2016, was only completed last year, serving as a case study for improving efficiency. Anwar urged states and local councils to fast-track land approvals for public health projects, learning from the contractor's performance and approval processes.
The health minister, Dzulkefly Ahmad, supported this initiative by reiterating the safety and effectiveness of generic drugs. He mentioned that the generic-first policy has led to wider prescription of these drugs in public health facilities, resulting in substantial savings. In the last two years, the government has saved at least RM900 million through this approach, and Dzulkefly predicts that the savings will continue to increase. However, he also addressed the delays in some health projects, stating that he and the works minister are reviewing these "sick" projects through a development committee. He emphasized the need for timely project delivery, acknowledging the inconvenience caused to the people who are eagerly awaiting these essential services.
